BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 34168979)

  • 1. Identification of Novel Alternative Splicing Events Associated With Tumorigenesis, Protein Modification, and Immune Microenvironment in Early-Onset Gastric Cancer.
    Zhang J; Goel A; Zhu L
    Front Oncol; 2021; 11():640272. PubMed ID: 34168979
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative investigation of early-onset gastric cancer.
    Ma Z; Liu X; Paul ME; Chen M; Zheng P; Chen H
    Oncol Lett; 2021 May; 21(5):374. PubMed ID: 33777198
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variation in Treatment Patterns of Patients with Early-Onset Gastric Cancer.
    LaPelusa M; Shen C; Gillaspie EA; Cann C; Lambright E; Chakravarthy AB; Gibson MK; Eng C
    Cancers (Basel); 2022 Jul; 14(15):. PubMed ID: 35892891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Status of CHEK2 and p53 in patients with early-onset and conventional gastric cancer.
    Machlowska J; Kapusta P; Szlendak M; Bogdali A; Morsink F; Wołkow P; Maciejewski R; Offerhaus GJA; Sitarz R
    Oncol Lett; 2021 May; 21(5):348. PubMed ID: 33747205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The clinicopathological characteristics of early-onset gastric cancer and its evolutionary trends: a retrospective study.
    Qu X; Zhao X; Liu Y; Wang N; Zhang L; Zhu X; Dong Q; Liu J; Shi Y
    Am J Cancer Res; 2022; 12(6):2757-2769. PubMed ID: 35812046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The landscape of alternative splicing reveals novel events associated with tumorigenesis and the immune microenvironment in gastric cancer.
    Lou S; Zhang J; Zhai Z; Yin X; Wang Y; Fang T; Xue Y
    Aging (Albany NY); 2021 Jan; 13(3):4317-4334. PubMed ID: 33428603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of Common Medications and the Risk of Early-Onset Gastric Cancer: A Population-Based Matched Study.
    MacArthur TA; Harmsen WS; Mandrekar J; Abraha F; Grotz TE
    J Cancer Epidemiol; 2021; 2021():2670502. PubMed ID: 34899912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Programmed death-1 and PD-1 ligand-1 expression in early onset gastric carcinoma and correlation with clinicopathological characteristics.
    Wei P; Jin M; Zhou X; Hu X; Wang Y
    Int J Clin Exp Pathol; 2018; 11(4):1989-1998. PubMed ID: 31938305
    [No Abstract]   [Full Text] [Related]  

  • 9. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
    Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W
    J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Specifics of Young Gastric Cancer Patients: A Population-Based Analysis of 46,110 Patients with Gastric Cancer from the German Clinical Cancer Registry Group.
    Kist M; Thomaschewski M; Keck Y; Abdalla TSA; Zeissig SR; Kleihues-van Tol K; Wellner UF; Keck T; Hoeppner J; Hummel R
    Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive characterization of the alternative splicing landscape in head and neck squamous cell carcinoma reveals novel events associated with tumorigenesis and the immune microenvironment.
    Li ZX; Zheng ZQ; Wei ZH; Zhang LL; Li F; Lin L; Liu RQ; Huang XD; Lv JW; Chen FP; He XJ; Guan JL; Kou J; Ma J; Zhou GQ; Sun Y
    Theranostics; 2019; 9(25):7648-7665. PubMed ID: 31695792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclin E low molecular weight isoforms occur commonly in early-onset gastric cancer and independently predict survival.
    Milne AN; Carvalho R; Jansen M; Kranenbarg EK; van de Velde CJ; Morsink FM; Musler AR; Weterman MA; Offerhaus GJ
    J Clin Pathol; 2008 Mar; 61(3):311-6. PubMed ID: 18305181
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global, Regional, and National Burdens with Temporal Trends of Early-, Intermediate-, and Later-Onset Gastric Cancer from 1990 to 2019 and Predictions up to 2035.
    Ning FL; Zhang NN; Zhao ZM; Du WY; Zeng YJ; Abe M; Pei JP; Zhang CD
    Cancers (Basel); 2022 Nov; 14(21):. PubMed ID: 36358835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune and Stroma Related Genes in Breast Cancer: A Comprehensive Analysis of Tumor Microenvironment Based on the Cancer Genome Atlas (TCGA) Database.
    Xu M; Li Y; Li W; Zhao Q; Zhang Q; Le K; Huang Z; Yi P
    Front Med (Lausanne); 2020; 7():64. PubMed ID: 32195260
    [No Abstract]   [Full Text] [Related]  

  • 15. Expression profile of E-cadherin, estrogen receptors, and P53 in early-onset gastric cancers.
    Zhou F; Xu Y; Shi J; Lan X; Zou X; Wang L; Huang Q
    Cancer Med; 2016 Dec; 5(12):3403-3411. PubMed ID: 27781410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Endoscopic and Clinicopathological Characteristics of Early-onset Gastric Cancer in Vietnamese Patients.
    Quach DT; Ha DV; Hiyama T
    Asian Pac J Cancer Prev; 2018 Jul; 19(7):1883-1886. PubMed ID: 30049355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive analysis of tumor immune microenvironment and prognosis of m6A-related lncRNAs in gastric cancer.
    Wang Y; Zhu GQ; Tian D; Zhou CW; Li N; Feng Y; Zeng MS
    BMC Cancer; 2022 Mar; 22(1):316. PubMed ID: 35331183
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-wide identification of alternative splicing and splicing regulated in immune infiltration in osteosarcoma patients.
    Dai Z; Sun Y; Maihemuti M; Jiang R
    Front Genet; 2023; 14():1051192. PubMed ID: 37139238
    [No Abstract]   [Full Text] [Related]  

  • 19. Comprehensive Characterization of Alternative Polyadenylation in Human Cancer.
    Xiang Y; Ye Y; Lou Y; Yang Y; Cai C; Zhang Z; Mills T; Chen NY; Kim Y; Muge Ozguc F; Diao L; Karmouty-Quintana H; Xia Y; Kellems RE; Chen Z; Blackburn MR; Yoo SH; Shyu AB; Mills GB; Han L
    J Natl Cancer Inst; 2018 Apr; 110(4):379-389. PubMed ID: 29106591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Distinct Clinicopathological Feature and Prognosis of Young Gastric Cancer Patients Aged ≤ 45 Years Old.
    Huang Q; Zheng X; Jiao Y; Lei Y; Li X; Bi F; Guo F; Wang G; Liu M
    Front Oncol; 2021; 11():674224. PubMed ID: 34513668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.